© 2021 Celltex Therapeutics Corporation. All rights reserved.
COVID-19 Updates from Celltex Therapeutics Learn More
Rick Perry Discusses Celltex's COVID-19 Clinical Trials on Fox News TV Watch Now
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. The journal Aging & Disease has recently reported on a study that has proven transplantation of mesenchymal stem cells has improved the outcome of 7 patients diagnosed with COVID-19 Pneumonia in Bejing, China.
Learn MoreThe COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. ChinaXiv has performed a recent study that has proven significant improvement of a critically ill COVID-19 patient that was treated with the transfer of human umbilical cord mesenchymal stem cells.
Learn MoreThe COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. Celltex is continuing to monitor and participate in this promising research.
Learn MoreWe have been closely monitoring the guidelines set forth from the Centers for Disease Control (CDC) and the World Health Organization (WHO) in response to COVID-19. The safety and health of our team, clients and community is extremely important to us and because of this, we are taking proper precautions in our corporate office and lab environment.
Learn More